ESH Video

John Goldman Award

The European School of Haematology (ESH) is proud to announce the 2nd John Goldman Award.

 

The recipient of this annual award will receive a total of 80K€ to finance or co-finance a research project on TREATMENT FREE REMISSION (TFR). The research project start date will be November 1st, 2020 and will have a maximum duration of two years.

Submitted projects must:

– aim to develop a method, algorithm or test to reliably identify patients able to benefit from treatment discontinuation, thereby significantly improving the probability of TFR success,

– demonstrate potential to improve healthcare standards for Chronic Myeloid Leukaemia (CML) patients or for patients suffering from other haematological malignancies.

Call for Applications (start date): November 20, 2019

Deadline for Submission: March 1st, 2020

 

DOWNLOAD THE CALL FOR APPLICATIONS TO COMPLETE THE FORM

 

For further information: Didi.jasmin@univ-paris-diderot.fr with copy to Camille.dufour@univ-paris-diderot.fr

European School of Haematology (ESH)

Saint-Louis Research Institute,

Saint-Louis Hospital,

Paris 75010, France

We invite you to watch the panel discussion video on the 1st John Goldman International Award on Treatment Free Remission with Hervé Dombret, ESH President (Moderator),

Daniela Krause, ESH Scientific Committee member, Georg-Speyer-Haus and Goethe University Frankfurt (Panelist), François-Xavier Mahon, ESH Scientific Committee past member, Institut Bergonié, Bordeaux (Panelist), Ilaria Pagani, 1st John Goldman Awardee, South Australian Health and Medical Research Institute, Adelaide (Panelist) and Ana Rita Ferreira, Medical Director CML, Novartis Europe (Panelist):

 

 

ESH extends sincere thanks to the 2019 Award reviewers:

Jorge Cortes (Augusta, USA)

Michael Hallek (Cologne, Germany)

Hervé Dombret (Paris, France)

Andreas Hochhaus (Jena, Germany)

Alessandro Vannucchi (Florence, Italy)

Andrew Rawstron (Leeds, UK)